Cargando…

Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities

The molecular events and transcriptional plasticity driving brain metastasis in clinically relevant breast tumor subtypes has not been determined. Here we comprehensively dissect genomic, transcriptomic and clinical data in patient-matched longitudinal tumor samples, and unravel distinct transcripti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cosgrove, Nicola, Varešlija, Damir, Keelan, Stephen, Elangovan, Ashuvinee, Atkinson, Jennifer M., Cocchiglia, Sinéad, Bane, Fiona T., Singh, Vikrant, Furney, Simon, Hu, Chunling, Carter, Jodi M., Hart, Steven N., Yadav, Siddhartha, Goetz, Matthew P., Hill, Arnold D. K., Oesterreich, Steffi, Lee, Adrian V., Couch, Fergus J., Young, Leonie S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791982/ https://www.ncbi.nlm.nih.gov/pubmed/35082299 http://dx.doi.org/10.1038/s41467-022-27987-5

Ejemplares similares

Dynamic epi‐transcriptomic landscape mapping with disease progression in estrogen receptor‐positive breast cancer
por: Keelan, Stephen, et al.
Publicado: (2023)

Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer
por: Browne, Alacoque L., et al.
Publicado: (2018)

ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis
por: Charmsaz, Sara, et al.
Publicado: (2020)

Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype
por: Varešlija, Damir, et al.
Publicado: (2021)

Proteomic and transcriptomic profiling identifies mediators of anchorage-independent growth and roles of inhibitor of differentiation proteins in invasive lobular carcinoma
por: Tasdemir, Nilgun, et al.
Publicado: (2020)

Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML
por: Hart, Steven N., et al.
Publicado: (2020)

Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets
por: Varešlija, Damir, et al.
Publicado: (2018)

Mutation prevalence tables for hereditary cancer derived from multigene panel testing
por: Hart, Steven N., et al.
Publicado: (2020)

The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort
por: Hu, Chunling, et al.
Publicado: (2020)

S100β as a serum marker in endocrine resistant breast cancer
por: Charmsaz, Sara, et al.
Publicado: (2017)

Estrogen-repressed genes – key mediators of estrogen action?
por: Zubairy, Simeen, et al.
Publicado: (2005)

RET signaling in breast cancer therapeutic resistance and metastasis
por: Pecar, Geoffrey, et al.
Publicado: (2023)

Dexamethasone promotes breast cancer stem cells in obese and not lean mice
por: Annett, Stephanie, et al.
Publicado: (2022)

The Werner syndrome helicase protein is required for cell proliferation, immortalization, and tumorigenesis in Scaffold Attachment Factor B1 deficient mice
por: Lachapelle, Sophie, et al.
Publicado: (2011)

Progestins: Pro-senescence therapy for ovarian cancer?
por: Oesterreich, Steffi, et al.
Publicado: (2013)

26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3–6 December 2003: update on preclinical and translational research
por: Lee, Adrian V, et al.
Publicado: (2004)

To bind or not to bind - FoxA1 determines estrogen receptor action in breast cancer progression
por: Watters, Rebecca J, et al.
Publicado: (2012)

Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment?
por: Steinman, Richard A, et al.
Publicado: (2012)

Estradiol as a Targeted, Late-Line Therapy in Metastatic Breast Cancer with Estrogen Receptor Amplification
por: Kota, Karthik, et al.
Publicado: (2017)

Role of sirtuins in attenuating plaque vulnerability in atherosclerosis
por: Velpuri, Prathosh, et al.
Publicado: (2023)

A clinically compatible drug‐screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis
por: Zhu, Lucía, et al.
Publicado: (2022)

Role of oncostatin-M in ECM remodeling and plaque vulnerability
por: Patel, Parth, et al.
Publicado: (2023)

Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer
por: Yadav, Siddhartha, et al.
Publicado: (2020)

Improving ChIP-seq peak-calling for functional co-regulator binding by integrating multiple sources of biological information
por: Osmanbeyoglu, Hatice Ulku, et al.
Publicado: (2012)

Precision Medicine in Hormone Receptor-Positive Breast Cancer
por: Nasrazadani, Azadeh, et al.
Publicado: (2018)

Shielding reduced incidence of COVID-19 in patients with inflammatory arthritis but vulnerability is associated with increased mortality
por: Cooksey, Roxanne, et al.
Publicado: (2022)

The role of single nucleotide polymorphisms in breast cancer metastasis
por: Rae, James M, et al.
Publicado: (2008)

Epigenetics in breast cancer: what's new?
por: Huang, Yi, et al.
Publicado: (2011)

The Use of Preliminary Scientific Evidence in Public Health: A Case Study of XMRV
por: Wilson, Kumanan, et al.
Publicado: (2014)

Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay
por: Hu, Chunling, et al.
Publicado: (2022)

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients
por: LaDuca, Holly, et al.
Publicado: (2019)

Vulnerability as practice in diagnosing multiple conditions
por: Coyle, Lindsay-Ann, et al.
Publicado: (2019)

RADI-03. A strategy to personalize the use of radiation in patients with brain metastasis based on S100A9-mediated resistance
por: Miarka, Lauritz, et al.
Publicado: (2021)

The Scaffold attachment factor b1 (Safb1) regulates myogenic differentiation by facilitating the transition of myogenic gene chromatin from a repressed to an activated state
por: Hernández-Hernández, J. Manuel, et al.
Publicado: (2013)

Clinical Outcomes and Prognostic Factors In Triple-Negative Invasive Lobular Carcinoma of the Breast
por: Joshi, Utsav, et al.
Publicado: (2023)

Network-guided prediction of aromatase inhibitor response in breast cancer
por: Ruffalo, Matthew, et al.
Publicado: (2019)

A novel panel of differentially-expressed microRNAs in breast cancer brain metastasis may predict patient survival
por: Giannoudis, Athina, et al.
Publicado: (2019)

The Child as Vulnerable Victim: Humanitarianism Constructs Its Object
por: Hart, Jason
Publicado: (2023)

How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer Research
por: Pate, Leigh, et al.
Publicado: (2021)

Erfassung direkter (COVID-19-bezogener) und kollateraler, psychosozialer Folgen für vulnerable Gruppen am Beispiel schwerer psychischer Erkrankungen
por: Ascone, Leonie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_54i3nkneu8vkch2f7i6ir74jvr